Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Kelly Warth joins the P/S/L Group network

She becomes managing director for Instar Europe

- PMLiVE

Prescient names vice president global head of advisory

Dr Debasish Talukdar joins the consultancy from Bain & Company

- PMLiVE

Alex Butler and Matt Baker launch Foundry3

The UK agency aims to combine science, creativity and innovation

The new rules of marketing and PR

How to reach your audience directly

- PMLiVE

Novo’s oral semaglutide ‘safe and well-tolerated’

Releases first phase III data on the new version of its diabetes treatment

- PMLiVE

Pfizer’s leukaemia drug Mylotarg backed for use in EU

The CHMP’s positive opinion could see the drug return to market after almost eight years

AstraZeneca AZ

CHMP backs AZ’s Lynparza for ovarian cancer maintenance

Studies show that the drug reduced risk of disease progression

- PMLiVE

Pharma’s first ‘performance marketing’ agency launched

Founded by Matt Lowe, performance.io aims to redefine online performance

- PMLiVE

Significant figures

Insmed’s Olaf Bartsch tells PME about the US biotech’s year of progress

- PMLiVE

Sigurdur Olafsson becomes CEO of Hikma

And Said Darwazah is appointed as executive chairman

Bone Therapeutics strengthens board with new chairman

Jean Stéphenne joins the cell therapy company from TiGenix

Gilead Sciences

Gilead signs $3bn-plus gene-editing deal with Sangamo

Will use the platform for new cell-based cancer therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links